Sort   by:  
 Page size 
Unknown12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity.
Not available
S-EPMC3960303 | biostudies-literature
UnknownFormation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura.
Not available
S-EPMC6709991 | biostudies-literature
UnknownInhibitory Investigations of Acyl-CoA Derivatives against Human Lipoxygenase Isozymes.
Not available
S-EPMC10341549 | biostudies-literature
UnknownInvestigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products.
Not available
S-EPMC10821779 | biostudies-literature
UnknownAntiplatelet Effects of DMPC-Based Synthetic High-Density Lipoproteins: Exploring Particle Structure and Noncholesterol Efflux Mechanisms.
Not available
S-EPMC12321405 | biostudies-literature
UnknownModified two-step emulsion solvent evaporation technique for fabricating biodegradable rod-shaped particles in the submicron size range.
Not available
S-EPMC5862786 | biostudies-literature
UnknownPotential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19.
Not available
S-EPMC7923868 | biostudies-literature
UnknownProtease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.
Not available
S-EPMC3035574 | biostudies-literature
UnknownIrreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates.
Not available
S-EPMC2713123 | biostudies-literature
UnknownSynthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice.
Not available
S-EPMC7821904 | biostudies-literature
Sort   by:  
 Page size